| 1) ON THE BASIS OF PATIENT FEEDBACK (DISSATISFIED, REDUCED/LACK OF EFFICACY)? |
|
|
|
|
| 1a) WHAT, FOR THE PATIENT, ARE THE FACTORS THAT CONTRIBUTE MOST TO PERCEIVED TREATMENT FAILURE? |
|
|
|
|
| PAIN INSUFFICIENTLY IMPROVED OR NOT IMPROVED? |
|
|
|
|
| POSTURE INSUFICIENTLY IMPROVED OR NOT IMPROVED? |
|
|
|
|
| OTHER? |
|
|
|
|
| 2) ON THE BASIS OF YOUR CLINICAL EXAMINATION? |
|
|
|
|
| IF SO, PERFORMED USING TWSTRS? |
|
|
|
|
| TSUI? |
|
|
|
|
| OTHER? |
|
|
|
|
| 2a) WHAT, FOR YOU, ARE THE FACTORS THAT CONTRIBUTE MOST TO PERCEIVED TREATMENT FAILURE? |
|
|
|
|
| PAIN INSUFFICIENTLY IMPROVED OR NOT IMPROVED? |
|
|
|
|
| POSTURE INSUFICIENTLY IMPROVED OR NOT IMPROVED? |
|
|
|
|
| OTHER? |
|
|
|
|
| 3) DO YOU CONSIDER REDUCING THE INTERVAL BETWEEN INJECTIONS TO BE A RELEVANT FACTOR FOR DEFINITION OF TREATMENT FAILURE? |
|
|
|
|
| 4) DO YOU CONFIRM THE DIAGNOSIS OF TREATMENT FAILURE WITH: |
|
|
|
|
| 4a) FRONTALIS TEST? |
|
|
|
|
| 4b) EXTENSOR DIGITORUM BREVIS TEST? |
|
|
|
|
| 4c) OTHER TEST? |
|
|
|
|
| 5) DO YOU PERFORM NEUTRALIZING ANTIBODY TESTING? |
|
|
|
|